Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
213M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
81.8M
-
Shares change
-
+5.95M
-
Total reported value, excl. options
-
$1.84B
-
Value change
-
+$128M
-
Put/Call ratio
-
2.47
-
Number of buys
-
75
-
Number of sells
-
-51
-
Price
-
$22.52
Significant Holders of INSMED Inc - Common stock, par value $0.01 per share (INSM) as of Q1 2018
157 filings reported holding INSM - INSMED Inc - Common stock, par value $0.01 per share as of Q1 2018.
INSMED Inc - Common stock, par value $0.01 per share (INSM) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.8M shares
of 213M outstanding shares and own 38.39% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (12.6M shares), FMR LLC (11.5M shares), BlackRock Inc. (7.73M shares), Palo Alto Investors LP (7.16M shares), VANGUARD GROUP INC (6.43M shares), JANUS HENDERSON GROUP PLC (6.25M shares), STATE STREET CORP (3.46M shares), ORBIMED ADVISORS LLC (2.93M shares), Redmile Group, LLC (2.17M shares), and Foresite Capital Management IV, LLC (1.8M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.